HCPLive Network


Statins May Reduce Risk of Progression of Renal Cancer
Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research published in the April issue of The Journal of Urology.
Task Force Recommends Ways to Improve Price Transparency
Price transparency frameworks, which provide price information presented in the context of other relevant information, should be developed to meet patients' needs, according to recommendations presented in a report from the Healthcare Financial Management Association.
Low Adherence Rates for Prostate Cancer Quality of Care Measures
Adherence to established prostate cancer quality of care measures is frequently low, with considerable regional variation, according to a study published in the April issue of The Journal of Urology.
American Medical Association Examines Economic Impact of Physicians
Physicians who mainly engage in patient care contribute a total of $1.6 trillion in economic output, according to the American Medical Association's Economic Impact Study.
White House: 8 Million People Signed Up for Health Insurance
Eight million Americans signed up for private health insurance during the just-concluded first enrollment period under the Affordable Care Act, the White House announced Thursday afternoon.
Patient-Clinician Relationship Impacts Health Care Outcomes
The patient-clinician relationship has a small but significant effect on health care outcomes, according to a study published online April 9 in PLOS ONE.
Educator Discusses Key Issues for Future Doctors to Consider
The key issues for future physicians are discussed in an article published by the American Medical Association.
Continued Reliance on Windows XP May Threaten Data Security
Physicians who use Windows XP in their practices may be affected by Microsoft's recent discontinuation of support for the program, according to an article published April 8 in Medical Economics.
Patients Paying Much More for Specialty Drugs
Many Americans are paying less for prescription drugs, but some are having to deal with sharp rises in the cost of specialty medicines for rare or serious diseases, according to a new report.
Medicines Regulator to Review Cardiovascular Risks of Testosterone Treatment
The European Medicines Agency has announced it will evaluate all medications containing testosterone for cardiovascular risk.
The 35th Oncology Nursing Society (ONS) Congress
The Society of Gynecologic Oncologists 41st Annual Meeting on Women's Cancer
American Society of Clinical Oncology 2009
Condition Centers